LYTIR

Insider · SEC Form 4 · Director

Silvestre Vila Moret

Filed with the SEC as Moret Silvestre Vila; the order above is the one the filer's own signature uses.

In the 12 months to Nov 8, 2026, on the open market: bought $4.3M of GGAL. Filed a median of 5 business days after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $4.3M in total; Insider sales: $0 in total.Jun: Insider purchases $1.6MJul: Insider purchases $2.7MDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $4.3MInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. GGALBought: GRUPO FINANCIERO GALICIA SA Jul 8, 2026 224,000 shares filed Jul 13, 2026 3,000,000 shares held directly after, as filed filing $1.2M
  2. GGALBought: GRUPO FINANCIERO GALICIA SA Jul 7, 2026 176,000 shares filed Jul 9, 2026 2 transactions filing $961K
  3. GGALBought: GRUPO FINANCIERO GALICIA SA Jul 1, 2026 100,000 shares filed Jul 9, 2026 2,600,000 shares held directly after, as filed filing $511K
  4. GGALBought: GRUPO FINANCIERO GALICIA SA Jun 30, 2026 167,791 shares filed Jul 9, 2026 2,500,000 shares held directly after, as filed filing $884K
  5. GGALBought: GRUPO FINANCIERO GALICIA SA Jun 29, 2026 10,000 shares filed Jul 9, 2026 2,332,209 shares held directly after, as filed filing $52K
  6. GGALBought: GRUPO FINANCIERO GALICIA SA Jun 26, 2026 125,000 shares filed Jul 9, 2026 2,322,209 shares held directly after, as filed filing $644K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.